Search research articles
Contact Us
Filters
Showing results (41-50 of 48) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 48 results.
Stroke
|
February 2, 2023
Association Between Hospital-Documented Atrial Fibrillation and Central Retinal Artery Occlusion
Jay B Lusk, Ailin Song, Shakthi Unnithan, et al.
Translational Vision Science & Technology
|
March 15, 2024
RobOCTNet: Robotics and Deep Learning for Referable Posterior Segment Pathology Detection in an Emergency Department Population
Ailin Song, Jay B Lusk, Kyung-Min Roh, et al.
Cancer Letters
|
December 24, 2024
Targeting UBE2T suppresses breast cancer stemness through CBX6-mediated transcriptional repression of SOX2 and NANOG
Keshen Wang, Qichen He, Xiangyan Jiang, et al.
Therapeutic Advances in Medical Oncology
|
March 9, 2023
Efficacy analysis of neoadjuvant chemotherapy with or without anthracyclines in female patients with HER2-positive breast cancer in China: a nationwide, multicenter, 10-year retrospective study (CSBrS-012)
Heyan Chen, Amina Maimaitiaili, Zhenzhen Liu, et al.
Iscience
|
July 18, 2025
Application of sentinel lymph nodes biopsy tracers for breast cancer after neoadjuvant chemotherapy in China: A multicenter, real-world study
Fengjiang Qu, Tinghan Jiang, Zhenzhen Liu, et al.
Journal of Cancer Research and Clinical Oncology
|
May 2, 2023
Nomogram for predicting axillary upstaging in clinical node-negative breast cancer patients receiving neoadjuvant chemotherapy
Amina Maimaitiaili, Heyan Chen, Peiling Xie, et al.
Frontiers in Oncology
|
May 27, 2024
A nomogram for predicting pathologic node negativity after neoadjuvant chemotherapy in breast cancer patients: a nationwide, multicenter retrospective cohort study (CSBrS-012)
Amina Maimaitiaili, Yijun Li, Na Chai, et al.
Breast (Edinburgh, Scotland)
|
January 26, 2024
Axillary lymph node dissection in triple-negative or HER2-positive breast cancer patients with clinical N2 achieving pathological complete response after neoadjuvant therapy: Is it necessary?
Xuhui Guo, Jiao Zhang, Xilong Gong, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 48) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 48 results.
Stroke
|
February 2, 2023
Association Between Hospital-Documented Atrial Fibrillation and Central Retinal Artery Occlusion
Jay B Lusk, Ailin Song, Shakthi Unnithan, et al.
Translational Vision Science & Technology
|
March 15, 2024
RobOCTNet: Robotics and Deep Learning for Referable Posterior Segment Pathology Detection in an Emergency Department Population
Ailin Song, Jay B Lusk, Kyung-Min Roh, et al.
Cancer Letters
|
December 24, 2024
Targeting UBE2T suppresses breast cancer stemness through CBX6-mediated transcriptional repression of SOX2 and NANOG
Keshen Wang, Qichen He, Xiangyan Jiang, et al.
Therapeutic Advances in Medical Oncology
|
March 9, 2023
Efficacy analysis of neoadjuvant chemotherapy with or without anthracyclines in female patients with HER2-positive breast cancer in China: a nationwide, multicenter, 10-year retrospective study (CSBrS-012)
Heyan Chen, Amina Maimaitiaili, Zhenzhen Liu, et al.
Iscience
|
July 18, 2025
Application of sentinel lymph nodes biopsy tracers for breast cancer after neoadjuvant chemotherapy in China: A multicenter, real-world study
Fengjiang Qu, Tinghan Jiang, Zhenzhen Liu, et al.
Journal of Cancer Research and Clinical Oncology
|
May 2, 2023
Nomogram for predicting axillary upstaging in clinical node-negative breast cancer patients receiving neoadjuvant chemotherapy
Amina Maimaitiaili, Heyan Chen, Peiling Xie, et al.
Frontiers in Oncology
|
May 27, 2024
A nomogram for predicting pathologic node negativity after neoadjuvant chemotherapy in breast cancer patients: a nationwide, multicenter retrospective cohort study (CSBrS-012)
Amina Maimaitiaili, Yijun Li, Na Chai, et al.
Breast (Edinburgh, Scotland)
|
January 26, 2024
Axillary lymph node dissection in triple-negative or HER2-positive breast cancer patients with clinical N2 achieving pathological complete response after neoadjuvant therapy: Is it necessary?
Xuhui Guo, Jiao Zhang, Xilong Gong, et al.
Page
of 5